exosomes/extracellular vesicles
The company plans to share new validation data, including an assessment of the test's lead time, at the upcoming American Society of Clinical Oncology annual meeting.
NeuroSense, Lonza Partner to Identify Exosome-Based Neurodegenerative Disease Biomarkers
The collaboration will initially support further development of NeuroSense's lead amyotrophic lateral sclerosis drug candidate, PrimeC.
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.
Biological Dynamics Partners With Pancreatic Cancer Consortium On Early Detection Study
The firm aims to recruit at least 1,000, and up to 5,000, individuals at an elevated risk for pancreatic cancer, comparing its test to standard-of-care surveillance.
Mercy BioAnalytics Raises $41M in Series A Financing
The proceeds will help develop and commercialize its extracellular vesicle-based Mercy Halo platform for lung, ovarian, and other cancer screening tests.